-- Market Insights
The need for in vitro diagnostics is increasing steadily due to the increasing incidence of chronic diseases, infections and the aging population at high risk. The growing scope of personalized medicine, molecular diagnostics and knowledge of the research and treatment of rare diseases further support the growth of the in-vitro diagnostic market. On the other hand, strict regulatory requirements and dicey reimbursements will prevent this market from holding back.
Get Sample @ https://www.credenceresearch.com/sample-request/57810
Reagents, instruments, software and services are the segmentation of the global market for in-vitro diagnostics. As a result of the large-scale consumption of these products over all IVS techniques, reagents account for over 30 percent of the entire market share in 2015. In addition, the software and services section is projected to grow at a faster rate during the outlook period, which is attributed to the rising need for widest automation and centralization of IVD processes and techniques at the same time.
Molecular diagnostics are considered the most remarkable IVD technique during the entire projection period. The increased applicability of MDx is attributed to its effectiveness in the understanding of the mechanism of disease and thus its vital role in the discovery of suitable and targeted treatments. Its prospects for the discovery of new drugs and personalized medicine also play an important role in facilitating the lucrative growth of the market throughout the project period. IVD is largely carried out in central laboratories, while its application in point-of-care testing continues to grow perpetually. However, over-the-counter or self-testing IVD will show the most significant growth rate in the near future with an increasing number of OTC test products offering cost efficiency and precise results.
Geographically, North America is the largest in-vitro diagnostics market, with the region taking over 35% market share in 2015. Fastest adoption of advanced technologies and rapid adoption of automation techniques in the diagnostic process are the prime features of North America IVD market. An increasing preference for molecular diagnostic in cancer screening will also facilitate steady growth in North America and Europe in-vitro diagnostics markets.
This market is mainly dominated by 5 players with a market share of 5 percent. This market is currently undertaken by multinationals in large-scale consolidation activities. The emergence of regional players is another important phenomenon on the world market for in vitro diagnostics. Among the major players on the market are Abbott Laboratories, Inc., Johnson and Johnson, Becton, Dickson and Company, Danaher Corporation, bioMérieux, Thermo Fisher Scientific, Inc. Company Sysmex and others.
Browse the full report Global In-vitro Diagnostics Market - Growth, Opportunities, Competitive Analysis, and Forecast, 2016 – 2022 at https://www.credenceresearch.com/report/in-vitro-diagnostics-ivd-market
Product types:
Reagents
Instruments
Software and Services
Test Locations Segmentation Investigation
Point-of-care testing, central lab testing and OTC/self testing are the locations where IVD is applied.
Based on the techniques :
Clinical Chemistry
Immunochemistry/Immunoassays
Hematology
Coagulation and Hemostasis
Microbiology
Molecular Diagnostics (MDX)
Others
Chapter 4 Global In-vitro Diagnostics Market Analysis, by Products
4.1 Preface
4.2 Reagents
4.3 Instruments
4.4 Software and Services
Chapter 5 Global In-vitro Diagnostics Market Analysis, by Techniques
5.1 Preface
5.2 Clinical Chemistry
5.3 Immunochemistry/Immunoassays
5.4 Hematology
5.5 Coagulation and Hemostasis
5.6 Microbiology
5.7 Molecular Diagnostics (MDX)
5.8 Others
Chapter 6 Global In-vitro Diagnostics Market Analysis, by Test Locations
6.1 Preface
6.2 Point-of-Care Testing
6.3 Central Lab Testing
6.4 OTC/Self Testing
Chapter 7 Global In-vitro Diagnostics Market, by Geography
7.1 Preface
7.2 North America
7.3 Europe
7.4 Asia-Pacific
7.5 Middle East and Africa (MEA)
7.6 Latin America
......................toc continued
Browse the full report Global In-vitro Diagnostics Market - Growth, Opportunities, Competitive Analysis, and Forecast, 2016 – 2022 at https://www.credenceresearch.com/report/in-vitro-diagnostics-ivd-market
Leading Players
Abbott Laboratories, Inc.
Bayer AG.
Becton, Dickson and Company
bioMérieux
Bio-Rad Laboratories, Inc.
Danaher Corporation
Johnson & Johnson Pvt Ltd.
Roche Diagnostics
Siemens AG
Sysmex Corporation
List Of Table :
TABLE 1 Global In-vitro Diagnostics Market, by Products, 2014 – 2022 (USD Mn)
TABLE 2 Global In-vitro Diagnostics Market, by Techniques, 2014 – 2022 (USD Mn)
TABLE 3 Global In-vitro Diagnostics Market, by Test Locations, 2014 – 2022 (USD Mn)
TABLE 4 Global In-vitro Diagnostics Market, by Geography, 2014 – 2022 (USD Mn)
TABLE 5 North America In-vitro Diagnostics Market, by Country, 2014 – 2022 (USD Mn)
TABLE 6 Europe In-vitro Diagnostics Market, by Country, 2014 – 2022 (USD Mn)
TABLE 7 Asia-Pacific In-vitro Diagnostics Market, by Country, 2014 – 2022 (USD Mn)
Browse the full report Global In-vitro Diagnostics Market - Growth, Opportunities, Competitive Analysis, and Forecast, 2016 – 2022 at https://www.credenceresearch.com/report/in-vitro-diagnostics-ivd-market
About Us
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.
Contact Info:
Name: Chris Smith
Email: Send Email
Organization: Credence Research
Address: 105 N 1st ST #429, SAN JOSE,, CA 95103, United States
Phone: 18003618290
Website: https://www.credenceresearch.com
Release ID: 476952
Google
RSS